首页> 美国卫生研究院文献>Colombia M dica : CM >Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease

【2h】

Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease

机译：血管紧张素转换酶抑制剂对老年痴呆患者老年性尿素和肌酐变化的药理作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Renal function declines according to age and vascular risk factors, whereas few data are available regarding genetically-mediated effects of anti-hypertensives over renal function.

机译：背景：肾脏功能会根据年龄和血管危险因素而下降，而关于高血压患者的遗传介导作用对肾脏功能的影响的数据很少。

著录项

期刊名称 Colombia M dica : CM
作者
Fabricio Ferreira de Oliveira; Juliana Marília Berretta; Elizabeth Suchi Chen; Marilia Cardoso Smith; Paulo Henrique Ferreira Bertolucci;
展开▼
作者单位

展开▼
年(卷),期 2016(47),2
年度 2016
页码 76–80
总页数 5
原文格式 PDF
正文语种
中图分类
关键词
Alzheimer disease pharmacogenetics urea creatinine Renin-Angiotensin System;

机译：阿尔茨海默氏病;药物遗传学;尿素;肌酐;肾素-血管紧张素系统;

相似文献

外文文献
中文文献
专利

1. Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease [J] . Elizabeth Suchi Chen, Fabricio Ferreira de Oliveira, Juliana Marília Berretta, Colombia Medica (Online) . 2016,第2期

机译：血管紧张素转换酶抑制剂对老年痴呆患者老年性尿素和肌酐变化的药理作用
2. COGNITIVE CHANGES ARE PHARMACOGENETICALLY MEDIATED BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH ALZHEIMER’S DISEASE DEMENTIA [J] . Fabricio Ferreira de Oliveira, Sandro Soares de Almeida, Elizabeth Suchi Chen, Alzheimer’s & dementia: the journal of the Alzheimer’s Association . 2018,第7期

机译：认知变化是通过血管紧张素转换酶抑制剂药物介导的阿尔茨海默病痴呆症
3. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia [J] . de Oliveira Fabricio Ferreira, Chen Elizabeth Suchi, Smith Marilia Cardoso, Current Alzheimer research . 2018,第4期

机译：阿尔茨海默病痴呆患者血管紧张素转化酶抑制剂的药物opmogy
4. Disrupted network topology in patients with Lewy bodies dementia compared to Alzheimer's disease, Parkinson disease dementia and Health Control^* [C] . Hucheng Zhou, Jiehui Jiang, Ping Wu, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：与阿尔茨海默氏病，帕金森氏病痴呆症和健康控制相比，路易氏体痴呆患者的网络拓扑结构破坏^*
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. Effects of Prolonged Angiotensin-converting Enzyme Inhibitor Treatment on Amyloid β-Protein Metabolism in Mouse Models of Alzheimer Disease [O] . Matthew L. Hemming, Dennis J. Selkoe, Wesley Farris -1

机译：长期使用血管紧张素转换酶抑制剂对阿尔茨海默病小鼠模型中淀粉样β蛋白代谢的影响
7. Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease [O] . Fabricio Ferreira de Oliveira, Juliana Marília Berretta, Elizabeth Suchi Chen, 2016

机译：血管紧张素转化酶抑制剂对痴呆患者年龄相关尿素和肌酐素变异的药物发生的影响，痴呆患者因阿尔茨海默病

Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease

摘要

著录项

相似文献

相关主题

期刊订阅